Tezacitabine (** Investigational compound (no established brand names - remained in clinical trial phases) **)

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

Tezacitabine is an investigational drug, meaning it is still being studied in clinical trials and is not yet approved for treating any condition, including colorectal cancer. It was being investigated as a potential treatment for metastatic colorectal cancer (cancer that has spread to other parts of the body). In clinical trials, tezacitabine was studied in combination with oxaliplatin, a chemotherapy drug commonly used for colorectal cancer. The goal of the trials was primarily to find the best dose of tezacitabine when given with oxaliplatin and to see if the combination could shrink tumors or slow their growth. As an investigational drug, its effectiveness and safety profile are still being determined.

Mechanism of Action

Tezacitabine is a nucleoside analog. Nucleoside analogs are a type of drug that interferes with the building blocks (nucleosides) that cells need to make DNA and RNA. By disrupting DNA and RNA synthesis, tezacitabine aims to stop cancer cells from growing and dividing. The specific way tezacitabine interacts with cellular processes is still being studied.

Side Effects

Because tezacitabine is an investigational drug Its full range of side effects is still being evaluated in ongoing clinical trials. Information about specific side effects from the trials is limited in the provided data. As with many cancer treatments Potential side effects could include fatigue Nausea Vomiting Diarrhea Low blood counts (affecting red blood cells White blood cells Or platelets) And other reactions. Patients participating in clinical trials are closely monitored for any adverse effects.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT00051688 Phase 2
Archived
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
United States

Quick Info

Brand Name** Investigational compound (no established brand names - remained in clinical trial phases) **
CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
781 trials
Leucovorin
Other Medications
641 trials
Paclitaxel
Other Medications
54 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Trifluridine
Other Medications
48 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.